newsfilter
← Latest News
PR Newswire·

Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing medicines that target the melanocortin receptor (MCR) system, ...